Factor VII Protein (Transcript Variant 2) (Myc-DYKDDDDK Tag)
Quick Overview for Factor VII Protein (Transcript Variant 2) (Myc-DYKDDDDK Tag) (ABIN2712925)
Target
See all Factor VII (F7) ProteinsProtein Type
Origin
Source
Application
Purity
-
-
Protein Characteristics
- Transcript Variant 2
-
Purification tag / Conjugate
- This Factor VII protein is labelled with Myc-DYKDDDDK Tag.
-
Characteristics
-
- Recombinant human Coagulation factor VII (F7) (transcript variant 2) protein expressed in HEK293 cells.
- Produced with end-sequenced ORF clone
-
-
Want other Options for this Protein ?
!Discover Our Predefined Custom Proteins and Custom Protein Services!Your project requires further customization? Contact us and discover our custom protein solutions
-
-
-
Application Notes
-
Recombinant human proteins can be used for:
Native antigens for optimized antibody production
Positive controls in ELISA and other antibody assays -
Comment
-
The tag is located at the C-terminal.
-
Restrictions
- For Research Use only
-
-
-
Concentration
- 50 μg/mL
-
Buffer
- 25 mM Tris.HCl, pH 7.3, 100 mM glycine, 10 % glycerol.
-
Storage
- -80 °C
-
Storage Comment
- Store at -80°C. Thaw on ice, aliquot to individual single-use tubes, and then re-freeze immediately. Only 2-3 freeze thaw cycles are recommended.
-
-
- Factor VII (F7) (Coagulation Factor VII (F7))
-
Background
- This gene encodes coagulation factor VII which is a vitamin K-dependent factor essential for hemostasis. This factor circulates in the blood in a zymogen form, and is converted to an active form by either factor IXa, factor Xa, factor XIIa, or thrombin by minor proteolysis. Upon activation of the factor VII, a heavy chain containing a catalytic domain and a light chain containing 2 EGF-like domains are generated, and two chains are held together by a disulfide bond. In the presence of factor III and calcium ions, the activated factor then further activates the coagulation cascade by converting factor IX to factor IXa and/or factor X to factor Xa. Defects in this gene can cause coagulopathy. Alternative splicing results in multiple transcript variants encoding different isoforms that may undergo similar proteolytic processing to generate mature polypeptides.
-
Molecular Weight
- 28 kDa
-
NCBI Accession
- NP_062562
-
Pathways
- Response to Growth Hormone Stimulus, Platelet-derived growth Factor Receptor Signaling
Target
-